Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive double bonds in membrane and plasma lipids, specifically those within polyunsaturated fatty acids (PUFAs), are critical chemical moieties that determine the structural and functional properties of biological membranes. These carbon-carbon double bonds, particularly at the bis-allylic positions, are highly susceptible to attack by reactive oxygen species (ROS), initiating a process known as lipid peroxidation (Yin et al., 2011, Chemical Reviews). This oxidative degradation is a hallmark of various pathologies, including atherosclerosis and neurodegenerative diseases, and is the execution mechanism for ferroptosis, a form of regulated cell death (Dixon et al., 2012, Cell). In therapeutic contexts, these double bonds are targeted by radical-trapping antioxidants like Vitamin E and experimental compounds like Ferrostatin-1, which protect the lipid bilayer from oxidative damage (Traber & Stevens, 2011, Free Radical Biology and Medicine). Conversely, medical ozone therapy utilizes the controlled reaction of ozone with these double bonds to generate lipid oxidation products that act as secondary messengers to modulate the immune system and antioxidant defenses (Bocci, 2006, "Ozone: A New Medical Drug"). Monitoring the integrity of these bonds is often achieved through biomarkers of lipid damage such as malondialdehyde and isoprostanes (Milne et al., 2005, Journal of Biological Chemistry).
Radical-trapping antioxidant (RTA) activity to prevent lipid peroxidation chain reactions; Electrophilic addition reactions (in the case of ozone therapy); Inhibition of iron-dependent enzymatic or non-enzymatic oxidation of bis-allylic carbons.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyunsaturated fatty acid double bonds (PUFA double bonds).